Mediworld Middle East

UPS is pushing #healthcare logistics to new heights! Recently, it announced its plans to acquire Germany-based Frigo-Trans GmbH and BPL, aiming to boost its #European healthcare portfolio. With this deal, UPS is doubling down on its commitment to provide top-tier, temperature-sensitive, and time-critical logistics for the rapidly evolving pharmaceutical industry. Here’s why this move is a game-changer: Temperature Control Expertise: Frigo-Trans operates across six temperature zones, from extreme cryopreservation (-196°C) to standard ambient (+15° to +25°C). This gives UPS Healthcare customers peace of mind when shipping fragile products. Pan-European Cold Chain Reach: By acquiring Frigo-Trans, UPS is strengthening its cold chain across Europe, meeting rising demand in pharma for reliable, temperature-controlled supply chains. Streamlined Healthcare Logistics: UPS has been on a healthcare-focused acquisition spree! Following MNX, Bomi Group, and Marken, this latest move takes them closer to their goal of $20 billion in healthcare logistics by 2026. With the healthcare logistics market valued at $130 billion, UPS is strategically investing to become the leader in complex, high-margin healthcare supply chains. Talk about staying cool under pressure! “The fast-paced innovation in the pharmaceutical industry is creating the need to have more integrated cold and frozen supply chains,” said UPS EVP and President of International, Healthcare and Supply Chain Solutions Kate Gutmann, in a statement. “Frigo-Trans will help deepen our portfolio of solutions for our customers and accelerate our journey to become the number one complex healthcare logistics provider in the world addressing their needs.” “UPS is continuing to build on its focus on healthcare,” said Ben Gordon, founder and managing partner of Palm Beach, Florida-based Cambridge Capital, and managing partner of Benjamin Gordon Strategic Advisors (BGSA). “Last year they acquired MNX. The prior year they bought Bomi Group. In 2016 they purchased Marken. And today they are buying Frigo-Trans and BPL. UPS has stated their intent to grow healthcare logistics from $10 billion in 2023 to $20 billion in 2026. They are onto something. The global healthcare logistics market is $130 billion. And cold chain services can be used for a broader range of temperature-controlled markets. This is a high-margin niche in the supply chain arena, and it gives UPS the opportunity to create a competitive edge.” What do you think—will UPS’s healthcare-focused investments give it a competitive edge in the global logistics landscape? #HealthcareLogistics #SupplyChainInnovation #ColdChainLogistics #PharmaLogistics #UPS #LogisticsTrends #dubai #Uae

Big news in the #dental industry! Archy has just secured $15 million in Series A funding to transform dental practices through #cloud-based automation. This round, led by Entrée Capital, will help Archy enhance its #AI capabilities to make dental teams more efficient and improve patient experiences. Why does this matter? Tackling Staffing Issues: With a 10% reduction in capacity and many dental professionals nearing retirement, there's an urgent need for innovative solutions. Streamlining Operations: Many practices are still stuck with outdated systems, making it tough to stay competitive. Archy's cloud-based solution eliminates the need for expensive on-premise servers and automates processes like billing, scheduling, and patient communication. Focusing on Patient Care: With integrated imaging and AI-powered analysis, Archy allows dental teams to concentrate on what truly matters—providing excellent care to their patients! Jonathan Rat, Archy's CEO, says: "Integrating Archy gives dental practices a fantastic opportunity to reshape their daily operations, freeing up time and resources for patient care and business improvements." Investors are on board! Avi Eyal from Entrée Capital points out that practices using Archy are already seeing significant boosts in efficiency and customer satisfaction. It’s an exciting time for innovation in this field! Kent Bennett, Partner at Bessemer Venture Partners added: “Dentists have a reputation for being tech-phobic, but the truth is that legacy platforms never gave them a reason to fall in love. Archy has changed that with an end-to-end product that’s a breeze to onboard. The company has seen impressive adoption this year that puts them in line with the most exciting vertical SaaS launches we’ve seen. We’re thrilled to partner with the company again in this round.” With this funding, Archy plans to roll out even more AI and #machinelearning features, particularly in analytics and revenue management. They’re already collaborating with hundreds of dental practices across the U.S., setting the stage for a brighter future in dental care. What are your thoughts on technology's role in #healthcare? Do you think innovations like Archy can truly enhance patient experiences? Let’s chat! #DentalTech #Healthcare #Innovation #CloudSolutions #AIinHealthcare #Archy #PatientExperience #dubai #uae #tech #digital

Exciting progress in the fight against #lymphedema! Swiss-based Lymphatica Medtech has secured €17.9 million in Series B funding to accelerate the clinical development of #LymphoDrain, a pioneering implantable device for lymphedema treatment. Here’s why this is a big step forward: Game-Changing Innovation: LymphoDrain is the first device of its kind—minimally invasive and designed to actively replace the lymphatic draining function, offering a much-needed option for patients. Strong Investor Support: Major backers like Panakes Partners, TechWald Holding S.p.A., and CDP Venture Capital SGR are investing in the vision. It’s great to see investor confidence behind a technology that could transform lives. Expanding Reach: With a new subsidiary in #Italy, Lymphatica is scaling up R&D, manufacturing, and clinical operations to bring this technology to those who need it most. Experienced Leadership: Industry expert Dan Rose joins as Chairman, bringing valuable experience to guide Lymphatica's growth. Meeting a Huge Need: Lymphedema affects over 10 million people globally, and treatment options are limited. LymphoDrain has the potential to be a transformative solution for millions. “We are thrilled to have closed our Series B financing, which will enable us to advance the clinical development of our groundbreaking technology for lymphedema patients,” said Dr. Marco Pisano, CEO and co-founder of Lymphatica Medtech. “With the support of our investors and new board members, we are one step closer to delivering a transformative solution that will significantly improve the lives of those suffering from lymphedema.” Valentina Triacca, COO and co-founder of Lymphatica Medtech, added: “Millions of people live with chronic lymphedema, and current treatment options fall short of providing effective relief. This investment allows us to continue advancing our LymphoDrain device, which has already shown promising results in a pilot feasibility study.” Alessio Beverina, Managing Partner at Panakès said: “Lymphatica is addressing a massive unmet medical need, with over 10 million people affected by lymphedema. This technology has the potential to transform the lives of those patients.” Dr. Lukas GUENTHER, CIO of TechWald added: "With its technology, Lymphatica is well-positioned to bring true sustainable clinical innovation in the treatment of lymphedema, greatly benefiting patients, physicians, and healthcare systems in various countries around the world." #LymphedemaCare #MedTechInnovation #HealthTech #SeriesBFunding #PatientCare #HealthcareSolutions #dubai #Uae #Medtech #digital #Innovation

Revolutionizing Life Science Research with SpectraPlex! Leica Microsystems has just raised the bar in spatial phenotyping with the launch of SpectraPlex! This innovative 3D high-multiplex solution for the STELLARIS confocal platform promises to transform how we explore complex biological systems. Here’s what you need to know: Enhanced Spatial Resolution. SpectraPlex allows researchers to capture more detailed 3D data, making it easier to study the intricate relationships between biological components. Integration with Omics Techniques. As Omics fields like Genomics and Proteomics continue to evolve, understanding spatiotemporal dynamics becomes crucial for revealing biological functions in health and disease. Real-Time Calculations Defining a panel in SpectraPlex triggers instant calculations to optimize microscope settings, maximizing your signal-to-noise ratio and minimizing crosstalk. Perfect for both novices and experts! Automated Data Generation The solution generates unmixed data and raw images automatically, streamlining your analysis process. Say goodbye to manual data management! AI-Powered Analysis With Aivia, Leica’s AI image analysis software, users can perform tailored segmentation and detailed downstream analysis, enhancing the interpretation of high-resolution 3D data. Leica Microsystems is setting new standards for understanding disease progression and identifying therapeutic targets. “SpectraPlex was developed to enable researchers to obtain more spatially resolved 3D data when interrogating complex disease states, allowing for a deeper analysis of pathological conditions," said James O'Brien, VP of Life Sciences and Applied Solutions at Leica Microsystems. “The data acquired using SpectraPlex can propel the discovery of new cell types, the identification of cell states and the mapping of functional relationships in a 3D spatial context, aiding in the understanding of disease progression and the identification of potential therapeutic targets.” What breakthroughs in life sciences are you most excited about? Share your thoughts in the comments! #LifeSciences #ResearchInnovation #3DImaging #SpatialPhenotyping #AIVision #LeicaMicrosystems

Exciting Breakthrough in #Biopharma Manufacturing The demand for monoclonal antibodies and #biopharmaceuticals is growing steadily, and with it, the need for more efficient production solutions. Enter Asahi Kasei Medical’s latest innovation—the Planova FG1 next-generation virus removal filter! What makes it stand out? 7x higher flux compared to previous models, speeding up virus filtration. Enhanced productivity with fewer risks of #virus breakthrough during pauses in filtration. High protein filtration and virus removal without requiring a prefilter. Planova FG1 is also compatible with standard CIP and SIP processes, making it easy to integrate with existing biopharma manufacturing equipment. And for companies scaling up production, there’s even better news—larger surface area filters are on the way! This is a significant step toward improving productivity in the biopharmaceutical industry, and it shows Asahi Kasei Medical’s dedication to providing safe and efficient solutions that patients and manufacturers can rely on. “Asahi Kasei Medical is thrilled to launch the Planova FG1 next-generation virus removal filter,” said Ken Shinomiya, President of Asahi Kasei Medical. “We look forward to continuing to support biopharmaceutical manufacturers with our broad and growing lineup of products that help them to safely and efficiently manufacture pharmaceuticals that patients can trust.” How do you see advancements like these shaping the future of biopharma production? Let’s chat in the comments! #BiopharmaInnovation #PharmaceuticalManufacturing #VirusRemoval #ProductivityBoost #BiotechSolutions #PlanovaFG1 #medtech #pharma #news #updates #dubai #Uae

Exciting Leadership Announcement in #Healthcare! M42 Health proudly announces the appointment of Dr. Summia Zaher as the new #CEO of Danat Al Emarat Hospital for Women & Children! With her at the helm, the hospital is set to continue its mission of excellence in women’s and children’s healthcare across the #GCC. Here’s what makes this announcement special: Over two decades of experience: Dr. Summia brings extensive expertise from the NHS in the U.K. and her leadership fellowship in obstetrics. Advancing women’s healthcare: She is committed to empowering patients through education and exceptional care, ensuring informed health decisions. Focus on innovation: Under her leadership, the hospital aims to strengthen its Research and Development initiatives, further enhancing patient outcomes. Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, emphasizes that Dr. Summia’s leadership will help set new standards in women’s healthcare, solidifying the hospital's reputation as a regional leader. He said: “Dr. Summia’s leadership and expertise are valuable to Danat Al Emarat Hospital for Women and Children’s mission to provide world-class care in the region. We are confident that under her leadership, the hospital will continue to set new standards in women’s healthcare and further cement its position as a leader.” Dr. Summia expresses her excitement: “I am honored to lead Danat Al Emarat as we advance women’s healthcare in the UAE and the region.” Her all-female executive team is dedicated to understanding and addressing patient needs, ensuring exceptional care for every woman and child. Danat Al Emarat Hospital is not just about treatment; it’s about comprehensive, patient-centered care. With a multidisciplinary team of specialists, they support women through every stage of their health journeys. Plus, they’re actively training the next generation of Emirati healthcare professionals! #HealthcareLeadership #WomensHealth #ChildrensCare #PatientCentric #M42 #DanatAlEmarat #dubai #uae #abudhabi

#Transforming #Dementia Support with #AI! Lenovo has launched Alzheimer’s Intelligence, a #3D avatar designed to help individuals and families facing dementia and Alzheimer’s. Here’s what makes it special: 24/7 Availability: The avatar offers #personalized advice based on real-life experiences. Natural Conversations: Users can engage in meaningful discussions about their unique challenges. Compassionate Guidance: The focus is on empathy, accuracy, and privacy. “With recent and ever-growing advancements in AI, we must harness this technology purposefully and responsibly for communities that may be overlooked by innovative technology,” said Doug Fisher, Chief Security and AI Officer at Lenovo. “This is part of our commitment to delivering Smarter AI for All—developing and deploying technology that can empower everyone at every scale.” “When people are first diagnosed with dementia, they can feel lost, with so many questions about what is happening. This AI doesn’t replace human contact but what it does do is offer a knowledgeable and compassionate source of assurance and advice based directly on the experiences and wisdom of other people with dementia,” said Steve Milton, Director, Innovations  in Dementia. Just imagine having a friendly companion to help navigate daily challenges! What are your thoughts on AI’s role in mental health support? I’d love to hear your perspective! #DementiaSupport #AI #Lenovo #Innovation #MentalHealth #AlzheimersIntelligence #dubai #Uae #digital #transformation

Medidata Solutions, a Dassault Systèmes brand, has unveiled Rave Lite, a powerful extension of their gold-standard Rave EDC software designed for Phase I and Phase IV studies. Here’s why Rave Lite is a game-changer: #Tailored Solutions: No matter your company size or focus, Rave Lite offers efficient electronic data capture and analysis solutions with a flexible pricing model. Streamlined Processes: It addresses technology fragmentation, reducing integration challenges and accelerating startup times. AI-Powered Accuracy: Medidata’s AI integration minimizes study misconfigurations, enhancing data integrity and ensuring precise trial designs. Tom Doyle, chief technology officer, Medidata, emphasizes the importance of having a single EDC platform across all phases. This flexibility empowers customers to scale their studies while maintaining Medidata’s high standards. Catch a sneak peek of Rave Lite at the NEXT New York conference on November 13-14! The solution will be available to customers in early 2025. How do you see technology shaping the future of clinical trials? Let’s discuss! #ClinicalTrials #Medidata #RaveLite #EDC #Healthcare #Innovation #LifeSciences #dubai #uae

We are thrilled to announce that Mediworld Middle East has received a Certificate of Appreciation for our invaluable role as a media partner at the EIOC - Excellence in Oncology Care event! Here’s what made the event so special: Inspiring #Connections: We had the chance to connect with passionate healthcare leaders and professionals dedicated to making a difference in #oncology. Sharing Knowledge: It was an incredible opportunity to learn about the latest advancements in cancer care and treatment options. Knowledge is key! Community Matters: This event highlighted the importance of collaboration in healthcare, showing that together we can achieve so much more for patients and families. A heartfelt thank you to everyone who contributed to this amazing event! Deepu Raj MOHAMMAD KARIMULLA Israr Ahmad Sunitha Sunilkumar Laique Khan #OncologyCare #HealthcareExcellence #MediworldMiddleEast #Collaboration #Innovation #CommunitySupport #dubai #uae #event

#AIDriven Drug Discovery: A New Era Begins with Iktos iktos is stepping up its game in AI-first drug discovery with the appointment of a powerhouse Scientific Advisory Board! These experts are here to revolutionize the way we design and develop new drugs, pushing the boundaries of innovation. Here’s a quick rundown of the impressive board members and what they bring to the table: Rafael Gómez Bombarelli: MIT professor and pioneer in #generativeAI for drug discovery. Thierry Masquelin: The mastermind behind @Lilly Life Science Studio (L2S2), helping to advance lab automation and #robotics. Friedrich Rippmann: A former Merck KGaA leader in computational chemistry and #biologics. Laurent Debussche: Ex-Sanofi VP with deep expertise in taking first-in-human drug candidates to #clinical trials. Dominique Bridon: A successful entrepreneur who knows how to balance scientific excellence with business success. These visionary leaders will help Iktos enhance its AI drug discovery platform, advance its robotic capabilities, and drive the company's pipeline toward commercialization. Why is this exciting? Because the future of healthcare is evolving, and AI is playing a key role in discovering life-saving drugs faster and more efficiently. What are your thoughts on AI transforming drug discovery? How do you see the role of AI in the future of healthcare? Let’s discuss in the comments! #DrugDiscovery #AIinHealthcare #Innovation #LabAutomation #ComputationalChemistry #Pharmaceutical #Innovation #dubai #Uae